Your browser doesn't support javascript.
loading
Pluripotent human stem cells as novel tools in drug discovery and toxicity testing.
Sartipy, Peter; Bjorquist, Petter; Strehl, Raimund; Hyllner, Johan.
Afiliación
  • Sartipy P; Cellartis AB, Arvid Wallgrens Backe 20, 413 46 Göteborg, Sweden. peter.sartipy@cellartis.com
IDrugs ; 9(10): 702-5, 2006 Oct.
Article en En | MEDLINE | ID: mdl-17016777
ABSTRACT
Improved technologies are urgently needed to develop effective and safe new drugs in a cost-efficient manner. Cell-based assays have many advantages in drug research, particularly because these assays can be adapted in a high-throughput format. In addition, technological advances in the areas of instrumentation and automation are providing expanding opportunities for high-content analyses. However, in cell-based research, none of these systems is particularly useful unless the cells that are being evaluated are clinically relevant. Pluripotent human stem cells are expected to revolutionize the accessibility to a variety of human cell types. The possibility to propagate pluripotent human stem cells and to subsequently differentiate these cells into desired target cell types will provide a stable supply of cells for a range of applications in drug discovery and toxicity testing. This feature discusses some of the research opportunities for pluripotent human stem cells.
Asunto(s)
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diseño de Fármacos / Pruebas de Toxicidad / Células Madre Pluripotentes Límite: Humans Idioma: En Revista: IDrugs Asunto de la revista: FARMACOLOGIA Año: 2006 Tipo del documento: Article País de afiliación: Suecia
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diseño de Fármacos / Pruebas de Toxicidad / Células Madre Pluripotentes Límite: Humans Idioma: En Revista: IDrugs Asunto de la revista: FARMACOLOGIA Año: 2006 Tipo del documento: Article País de afiliación: Suecia